These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1664888)

  • 21. Comparison between areas with Gd-EOB-DTPA uptake and without in hepatocellular carcinomas on Gd-EOB-DTPA-enhanced hepatobiliary-phase MR imaging: pathological correlation.
    Lee S; Kim SH; Park CK; Kim YS; Lee WJ; Lim HK
    J Magn Reson Imaging; 2010 Sep; 32(3):719-25. PubMed ID: 20815073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Biliary enhanced MR imaging by Gd-DTPA].
    Ohkawa S; Fujikura Y; Kanai T; Hiramatsu K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1992 May; 52(5):679-81. PubMed ID: 1508641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Staging of rectal cancer: assessment with Gd-DTPA enhanced MR imaging].
    Okizuka H; Sugimura K; Shiraki S; Ishida T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Apr; 53(4):403-9. PubMed ID: 8493073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnetic resonance imaging with gadolinium-DTPA for detecting cardiac transplant rejection in rats.
    Konstam MA; Aronovitz MJ; Runge VM; Kaufman DM; Brockway BA; Isner JM; Katzen NA; Dresdale AR; Diehl JT; Kaplan E
    Circulation; 1988 Nov; 78(5 Pt 2):III87-94. PubMed ID: 3052922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnostic strategy in liver and pancreatic tumors: imaging diagnosis using MRT].
    Langkowski JH
    Rontgenblatter; 1989 Sep; 42(9):400-5. PubMed ID: 2552566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic tumors: dynamic MR imaging.
    Ohtomo K; Itai Y; Yoshikawa K; Kokubo T; Yashiro N; Iio M; Furukawa K
    Radiology; 1987 Apr; 163(1):27-31. PubMed ID: 3029804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Gd-DTPA-enhanced MR imaging of the normal facial nerve].
    Saiwai S; Nishikawa J; Kawabe J; Fukuda H; Usuki N; Nakajima H; Miyamoto T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Jul; 52(7):1027-9. PubMed ID: 1508647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Role of gadolinium (Gd-DTPA) in the staging of renal carcinoma using magnetic resonance. Comparative evaluation with computerized tomography and magnetic resonance without contrast media].
    De Cobelli F; Vanzulli A; Colombo E; Bonato C; Sironi S; Del Maschio A
    Radiol Med; 1993 May; 85(5):562-9. PubMed ID: 8327756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracranial ganglioglioma: MR imaging.
    Algra PR; Scheltens P; Barkhof F; Valk J
    AJR Am J Roentgenol; 1990 Oct; 155(4):899-900. PubMed ID: 2119137
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of gadolinium-DTPA and polylysine-gadolinium-DTPA--enhanced magnetic resonance imaging of hepatocarcinoma in the rat.
    Grandin C; Van Beers BE; Demeure R; Goudemant JF; Mottet I; Pringot J
    Invest Radiol; 1995 Oct; 30(10):572-81. PubMed ID: 8557496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Basic analysis of dynamic study in cases of hepatocellular carcinoma using inversion recovery snap shot FLASH MR imaging with Gd-DTPA.
    Suto Y; Kamba M; Kato T; Ohta Y
    Radiat Med; 1995; 13(2):89-94. PubMed ID: 7667515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrolamellar hepatocellular carcinoma: MR appearance mimicking focal nodular hyperplasia.
    Hamrick-Turner JE; Shipkey FH; Cranston PE
    J Comput Assist Tomogr; 1994; 18(2):301-4. PubMed ID: 8126288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic MR imaging of hepatic adenomas with pathologic correlation.
    Miyazaki T; Yamashita Y; Yamamoto H; Yoshimatsu S; Takahashi M; Ogawa M; Ishimaru Y
    Comput Med Imaging Graph; 1994; 18(5):373-80. PubMed ID: 7954314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histologic basis for increased extraocular muscle enhancement in gadolinium-enhanced MR imaging.
    Kaissar G; Kim JH; Bravo S; Sze G
    Radiology; 1991 May; 179(2):541-2. PubMed ID: 2014307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnetic resonance imaging of liver tumors.
    Weissleder R; Stark DD
    Semin Ultrasound CT MR; 1989 Feb; 10(1):63-77. PubMed ID: 2560665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [3D-MR angiography(MRA)].
    Sadaoka S
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():296-8. PubMed ID: 11761960
    [No Abstract]   [Full Text] [Related]  

  • 37. [5. Inspection of Hepatocellular Carcinoma 3-Contrast for the Diagnosis of Hepatocellular Carcinoma: Techniques of Image Contrast and the Choice of MR Contrast Agent].
    Kitoh Y
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2016 May; 72(5):441-51. PubMed ID: 27211090
    [No Abstract]   [Full Text] [Related]  

  • 38. [MR imaging during arterio-portography (MR-AP) in the detection of hepatic cancer].
    Kajiya Y; Ikeda K; Kajiya Y; Inoue H; Miyazono N; Kanetsuki I; Takeshita T; Nakajo M; Fukushima N
    Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Sep; 52(9):1325-7. PubMed ID: 1437539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The recent progress of MRI].
    Nawano S; Nasu K; Murakami K; Kuroki Y; Fujikawa H
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():288-91. PubMed ID: 11761958
    [No Abstract]   [Full Text] [Related]  

  • 40. Gd-DTPA-DeA: a novel, liver-specific MRI contrast agent.
    Kawamura Y
    Acad Radiol; 2002 May; 9 Suppl 1():S102-3. PubMed ID: 12019839
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.